A Multiplexed System for Quantitative Comparisons of Chromatin Landscapes

Molecular Cell

Volumn 61, Issue 1, 2016, Pages 170-180

  van Galen, Peter ^a,b,c   Viny, Aaron D ^d   Ram, Oren ^a,b,c   Ryan, Russell J H ^a,b,c   Cotton, Matthew J ^a,b,c,e   Donohue, Laura ^a,b,c,e   Sievers, Cem ^a,b,c   Drier, Yotam ^a,b,c   Liau, Brian B ^a,b,c   Gillespie, Shawn M ^a,b,c,e   Carroll, Kaitlin M ^f   Cross, Michael B ^f   Levine, Ross L ^d   Bernstein, Bradley E ^a,b,c,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2; TRANSCRIPTION FACTOR EZH2; CHROMATIN; HISTONE;

ARTICLE; CHROMATIN; COMPARATIVE STUDY; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE MUTATION; HEMATOPOIETIC STEM CELL; HISTONE MODIFICATION; HUMAN; HUMAN CELL; QUANTITATIVE STUDY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DNA BARCODING; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; K-562 CELL LINE; LEUKEMIA; METABOLISM; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; PROCEDURES;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DNA BARCODING, TAXONOMIC; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HUMANS; K562 CELLS; LEUKEMIA; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION;

EID: 84953637104     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.11.003     Document Type: Article

References (33)

1. Adli M., Zhu J., Bernstein B.E. Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors. Nat. Methods 2010, 7:615-618.
2. Andersen C.L., Asmar F., Klausen T., Hasselbalch H., Grønbæk K. Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones. Leuk. Res. Rep. 2012, 2:1-3.
3. Bonhoure N., Bounova G., Bernasconi D., Praz V., Lammers F., Canella D., Willis I.M., Herr W., Hernandez N., Delorenzi M. Quantifying ChIP-seq data: a spiking method providing an internal reference for sample-to-sample normalization. Genome Res. 2014, 24:1157-1168. CycliX Consortium.
4. Brind'Amour J., Liu S., Hudson M., Chen C., Karimi M., Lorincz M. An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations. Nat. Comms. 2015, 6:1157.
5. Chabbert C.D., Adjalley S.H., Klaus B., Fritsch E.S., Gupta I., Pelechano V., Steinmetz L.M. A high-throughput ChIP-Seq for large-scale chromatin studies. Mol. Syst. Biol. 2015, 11:777.
6. Daley T., Smith A.D. Predicting the molecular complexity of sequencing libraries. Nat. Methods 2013, 10:325-327.
7. Dunham I., Kundaje A., Aldred S., Collins P., Davis C., Doyle F., Epstein C., Frietze S., Harrow J., Kaul R., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
8. Farh K.K., Marson A., Zhu J., Kleinewietfeld M., Housley W.J., Beik S., Shoresh N., Whitton H., Ryan R.J., Shishkin A.A., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015, 518:337-343.
9. Ferrari K., Scelfo A., Jammula S., Cuomo A., Barozzi I., Stützer A., Fischle W., Bonaldi T., Pasini D. Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity. Mol. Cell 2013, 53:49-62.
10. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., Robinson J., Minie B., Chevrier N., Itzhaki Z., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
11. Gilfillan G.D., Hughes T., Sheng Y., Hjorthaug H.S., Straub T., Gervin K., Harris J.R., Undlien D.E., Lyle R. Limitations and possibilities of low cell number ChIP-seq. BMC Genomics 2012, 13:645.
12. Grzybowski A.T., Chen Z., Ruthenburg A.J. Calibrating ChIP-Seq with nucleosomal internal standards to measure histone modification density genome wide. Mol. Cell 2015, 58:886-899.
13. Handley A., Schauer T., Ladurner A.G., Margulies C.E. Designing cell-type-specific genome-wide experiments. Mol. Cell 2015, 58:621-631.
14. Hoeijmakers W.A., Bártfai R., Françoijs K.-J., Stunnenberg H.G. Linear amplification for deep sequencing. Nat. Protoc. 2011, 6:1026-1036.
15. Jaffe J.D., Wang Y., Chan H.M., Zhang J., Huether R., Kryukov G.V., Bhang H.E., Taylor J.E., Hu M., Englund N.P., et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 2013, 45:1386-1391.
16. Krogan N.J., Lippman S., Agard D.A., Ashworth A., Ideker T. The cancer cell map initiative: defining the hallmark networks of cancer. Mol. Cell 2015, 58:690-698.
17. Kurimoto K., Yabuta Y., Hayashi K., Ohta H., Kiyonari H., Mitani T., Moritoki Y., Kohri K., Kimura H., Yamamoto T., et al. Quantitative dynamics of chromatin remodeling during germ cell specification from mouse embryonic stem cells. Cell Stem Cell 2015, 16:517-532.
18. Labelle, M., Boesen, T., Mehrotra, M., Khan, Q., and Ullah, F. April 2014. Inhibitors of histone demethylases. International patent. WO2014053491A1.
19. Lara-Astiaso D., Weiner A., Lorenzo-Vivas E., Zaretsky I., Jaitin D.A., David E., Keren-Shaul H., Mildner A., Winter D., Jung S., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 2014, 345:943-949.
20. Laurenti E., Doulatov S., Zandi S., Plumb I., Chen J., April C., Fan J.-B., Dick J.E. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat. Immunol. 2013, 14:756-763.
21. Liu C.L., Schreiber S.L., Bernstein B.E. Development and validation of a T7 based linear amplification for genomic DNA. BMC Genomics 2003, 4:19.
22. Lund K., Adams P.D., Copland M. EZH2 in normal and malignant hematopoiesis. Leukemia 2013, 28:44-49.
23. McCabe M.T., Ott H.M., Ganji G., Korenchuk S., Thompson C., Van Aller G.S., Liu Y., Graves A.P., Della Pietra A., Diaz E., et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012, 492:108-112.
24. McCabe M.T., Graves A.P., Ganji G., Diaz E., Halsey W.S., Jiang Y., Smitheman K.N., Ott H.M., Pappalardi M.B., Allen K.E., et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc. Natl. Acad. Sci. USA 2012, 109:2989-2994.
25. O'Neill L.P., VerMilyea M.D., Turner B.M. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat. Genet. 2006, 38:835-841.
26. Orlando D.A., Chen M.W., Brown V.E., Solanki S., Choi Y.J., Olson E.R., Fritz C.C., Bradner J.E., Guenther M.G. Quantitative ChIP-Seq normalization reveals global modulation of the epigenome. Cell Rep. 2014, 9:1163-1170.
27. Ryan R.J., Bernstein B.E. Molecular biology. Genetic events that shape the cancer epigenome. Science 2012, 336:1513-1514.
28. Ryan R.J., Nitta M., Borger D., Zukerberg L.R., Ferry J.A., Harris N.L., Iafrate A.J., Bernstein B.E., Sohani A.R., Le L.P. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS ONE 2011, 6:e28585.
29. Shankaranarayanan P., Mendoza-Parra M.-A., Walia M., Wang L., Li N., Trindade L.M., Gronemeyer H. Single-tube linear DNA amplification (LinDA) for robust ChIP-seq. Nat. Methods 2011, 8:565-567.
30. Sneeringer C.J., Scott M.P., Kuntz K.W., Knutson S.K., Pollock R.M., Richon V.M., Copeland R.A. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc. Natl. Acad. Sci. USA 2010, 107:20980-20985.
31. Tang G.-Q., Bandwar R.P., Patel S.S. Extended upstream A-T sequence increases T7 promoter strength. J. Biol. Chem. 2005, 280:40707-40713.
32. Wigle T.J., Knutson S.K., Jin L., Kuntz K.W., Pollock R.M., Richon V.M., Copeland R.A., Scott M.P. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states. FEBS Lett. 2011, 585:3011-3014.
33. Zhu J., Adli M., Zou J.Y., Verstappen G., Coyne M., Zhang X., Durham T., Miri M., Deshpande V., De Jager P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.